SPC459

Elvitegravír og tenófóvíralafenamíð

  • Status:
    Veitt
  • Application date:
    18.3.2024
  • Application published:
    15.4.2024
  • Grant published:
    15.9.2025
  • Max expiry date:
    18.5.2030
  • Next due date:
    31.5.2026
  • Medicine name:
    Genvoya
  • Medicine for children:
    Yes

Timeline

Today
18.3.2024Application
15.4.2024Publication
15.9.2025Registration
18.5.2026Expires

Marketing license

  • IS authorization number:
    EU/1/15/1061
  • Date:
    9.12.2015
  • Foreign authorization number:
    EU/1/15/1061
  • Date:
    19.11.2015

Owner

  • Name:
    Japan Tobacco Inc.
  • Address:
    1-1, Toranomon 4-chome Minato-ku, Tokyo 105-6927 JP

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Annual fees

Number

Paid

Expires

Payer

Number: 1

Paid: 19.5.2025

Expires: 18.5.2026

Payer: Árnason Faktor ehf.

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 07.09.2025

Upload documents